- OMXSPI 0.97% 795.37
- FN25 1.29% 2239.33
- OMXS30 0.83% 2155.49
Toleranzia
First North Stockholm
0.53
0.02 3.11 %
Stock information
- Company Toleranzia
- Currency SEK
- Turnover 12 248 SEK
- % 3.11
- + / - 0.02
- Buy -
- Sell -
- High 1.4
- Low -
- Last updated 2023-09-29 17:25
Company information
Toleranzia is a research company focused on the development of drug candidates for the treatment of autoimmune diseases. The company has developed a platform technology focused on the muscular disease myasthenia gravis. In addition, the technology has been used in other areas such as diabetes and multiple sclerosis. Research collaboration is done together with external partners within the field. The head office is based in Gothenburg.
- Number of shares 197 Millions
- Stock market value 104 MSEK
- Average daily turnover 196 TSEK
- CEO Charlotte Fribert
- Chairman of the Board Ann-Charlotte Rosendahl
- Volatility 30 days 92.35%
- Volatility 200 days 56.52%
- Dividend -
- Latest annual report -
- Absolute return -
Owners
| Name | Ownership | Last modified |
|---|---|---|
| Flerie Invest AB | 47.4% | 2023-06-30 |
| Avanza Pension | 2.7% | 2023-06-30 |
| Nordnet Pensionsförsäkring | 2.5% | 2023-06-30 |
| S & B Christensen AB | 2% | 2023-06-30 |
| Nordea Livförsäkring Sverige AB | 1.8% | 2023-06-30 |
| Nordic Tender AB | 1.4% | 2023-06-30 |
| Konstruktions o Försäljnings AB KFAB | 1.1% | 2023-06-30 |
| Kaufmann, Johan | 1% | 2023-06-30 |
| Bergström, Niklas Tobias | 0.9% | 2023-06-30 |
| Navcap AB | 0.9% | 2023-06-30 |